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Abstract
The cystatin protein superfamily is characterized by the presence of conserved sequences that display cysteine protease
inhibitory activity (e.g., towards cathepsins). Type 1 and 2 cystatins are encoded by 25 genes of which 23 are grouped in 2
clusters localized on mouse chromosomes 16 and 2. The expression and essential roles of most of these genes in mouse
development and hematopoiesis remain poorly characterized. In this study, we describe a set of quantitative real-time PCR
assays and a global expression profile of cystatin genes in normal mouse tissues. Benefiting from our collection of DelES
embryonic stem cell clones harboring large chromosomal deletions (to be reported elsewhere), we selected a clone in
which a 95-kb region of chromosome 16 is missing (Del
16qB3D/+). In this particular clone, 2 cystatin genes, namely Csta and
Stfa2l1 are absent along with 2 other genes (Fam162a, Ccdc58) and associated intergenic regions. From this line, we
established a new homozygous mutant mouse model (Del
16qB3D/16qB3D) to assess the in vivo biological functions of the 2
deleted cystatins. Stfa2l1 gene expression is high in wild-type fetal liver, bone marrow, and spleen, while Csta is ubiquitously
expressed. Homozygous Del
16qB3D/16qB3D animals are phenotypically normal, fertile, and not overtly susceptible to
spontaneous or irradiation-induced tumor formation. The hematopoietic stem and progenitor cell activity in these mutant
mice are also normal. Interestingly, quantitative real-time PCR expression profiling reveals a marked increase in the
expression levels of Stfa2l1/Csta phylogenetically-related genes (Stfa1, Stfa2, and Stfa3)i nDel
16qB3D/16qB3D hematopoietic
tissues, suggesting that these candidate genes might be contributing to compensatory mechanisms. Overall, this study
presents an optimized approach to globally monitor cystatin gene expression as well as a new mouse model deficient in
Stfa2l1/Csta genes, expanding the available tools to dissect cystatin roles under normal and pathological conditions.
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Introduction
Chromosomal deletions are a powerful tool to assess the
biological functions and genetic interactions among contiguous
genomic elements irrespective of whether they are protein-coding
or non-coding. We have previously developed a retroviral-based
Cre-loxP system to engineer chromosomal deletions in mouse
embryonic stem cells (ESCs) that can successfully be submitted to
in vitro and in vivo haploinsufficient screens [1]. Among the mutant
ESC clones previously generated, the clone 7–30 is characterized
by a 95-kb haploid deletion mapped on chromosome 16
(Del
16qB3D/+) that does not perturb its potential to differentiate
normally into embryoid bodies [1]. Mapping of the rearrangement
breakpoints by inverse-PCR revealed that the deletion spans four
genes: Fam162a (partially deleted), Ccdc58 (completely deleted),
Csta (completely deleted), and Stfa2l1 (completely deleted) [1].
Fam162a codes for the mitochondrial protein Fam162a (also
known as growth and transformation-dependent protein), thought
to be a death-inducing effector downstream of hypoxia-inducible
factor 1a [2]. Ccdc58 codes for the Coiled-coil domain-containing
protein 58 [3], which currently has no known functions.
Microarray-based expression profiling suggests that Fam162a and
Ccdc58 are expressed during mouse embryogenesis and in a wide
variety of tissues of adult animals [4]. Enhanced Fam162a
cytoplasmic expression is detected in human gastric carcinoma
and adenoma compared to normal mucosa but the role of this
protein in tumorigenesis is undetermined [5]. The two other
deleted genes, Csta (protein: Cystatin A, also known as Stefin A)
and Stfa2l1 (protein: Stefin A2-like 1), are part of a stefin gene
cluster (n=10 genes: Csta, Stfa2l1, Gm5483, Gm5416,
2010005H15Rik, Stfa1, BC117090, BC100530, Stfa2, Stfa3) present
on mouse chromosome 16 [3]. The stefin proteins, a subgroup
(Type 1) of the cystatin superfamily, act as cytoplasmic inhibitors
of cysteine proteases such as cathepsins [6,7]. Given their
inhibitory role toward cathepsins, stefin proteins could regulate
antigen presentation processes involved in immune response and
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reveals that Stfa2l1 is mainly expressed in early embryos (E6.5), in
the umbilical cord, and in the bone, bone marrow, spleen, and
thyroid of adult mice [4]. Csta expression is observed in the
epidermis, bone marrow (subset of myeloid cells), spleen (cells
dispersed in red pulp), and oesophagus of adult mice [9,10]. Csta
expression is modulated in a variety of human cancers
[10,11,12,13,14]. The functional role of Cystatin A in these
cancers has not been completely elucidated. In a human
esophageal squamous cell carcinoma xenograft model or in a
syngenic murine model of mammary gland tumorigenesis, tumor
cells overexpressing Csta demonstrate a reduced capacity to form
lung or bone metastasis respectively, suggesting that Cystatin A
may act as a tumor suppressor within these contexts [15,16]. So
far, no mouse models deficient in Fam162a, Ccdc58, Csta,o rStfa2l1
have been described.
In the present study, we have generated homozygous null
Del
16qB3D/16qB3D mice and have shown that Csta and Stfa2l1 are
dispensable for viability, fertility and hematopoietic stem cell
activity. We also document the expression of most cystatin genes
in normal hematopoietic tissues and provide evidence for
compensation by phylogenetically-related family members in
Del
16qB3D/16qB3D cells.
Materials and Methods
Ethics statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant national and/or local animal
welfare bodies, and all animal work was approved by the
appropriate committee (University of Montreal animal ethics
committee: Comite ´d eD e ´ontologie de l’Expe ´rimentation sur les
Animaux de l’Universite ´ de Montre ´al. Protocols 08-113 and 08-
159). Animals were housed in ventilated cages and provided with
sterilized food and acidified water under veterinary supervision.
Maintenance and engineering of mouse ESCs
Chromosomal deletions were previously engineered in R1 ESCs
[17] with a retroviral-based Cre-loxP system [1]. ESCs were
maintained as described [1]. The chromosomal deletion found in
the karyotypically stable ESC clone used for this study (clone 7–30)
was previously mapped on mouse chromosome 16 (36071173–
36166797, NCBI mouse Build 37) by inverse-PCR [1].
Mutant mouse generation and genotyping
Chimeric mice were generated by injecting the engineered
ESCs into C57BL/6J morulas and blastocysts. Two highly
chimeric males were crossed with C57BL/6J females to achieve
germline transmission of the mutant allele. Heterozygous mutant
mice were intercrossed to establish a stable colony of homozygous
mice. Genotyping was performed by PCR using genomic DNA
extracted from tail clips (lysis with of 100 mM NaCl, 10 mM Tris
pH 8.0, 25 mM EDTA pH 8.0, 0.5% SDS, and 2.5 ug/ml
Proteinase K followed by phenol-chloroform extraction and
ethanol precipitation) or Sigma REDExtract-N-Amp
TM Tissue
PCR kit (primers are described in the Table S1). Southern blot
analysis was performed as previously described [18] with EcoRI-
digested genomic DNA from tail clips (EcoRI cleaves once inside
the recombined retroviral vectors) and a neomycin probe.
PCR analysis of the chromosomal deletion
The deleted chromosomal segment was confirmed by PCR
performed on genomic DNA extracted from mouse tail clips (see
above) using a set of PCR assays described in Table S2.
Mouse response to stimuli (visual, aural, pain) and
neuromuscular function
The visual response was evaluated by a menace response test
whereby an immediate reaction from the mouse is provoked by
quickly moving a finger towards the mouse. The aural response
was evaluated by observing that the mouse flicked its ears
backwards in response to aural stimulus. The response to pain was
evaluated by its response to tail pinch stimulus. Neuromuscular
function was evaluated by the grip strength test where mice grasp a
metal grid when lifted by the tail, as well as by the mouse’s ability
to support its hind end.
Clinical hematology, serum biochemistry and urinal-
ysis based on standardized assays were performed by the McGill
University Animal Resources Centre (http://www.medicine.
mcgill.ca/arc/).
Histology
E12.5, E14.5, E16.5 fetuses and dissected organs from adult
mice (3 months of age) were fixed overnight in a 10% buffered
formalin solution (Sigma-Aldrich) at room temperature, dehydrat-
ed, paraffin-embedded, and sectioned according to standard
procedures. Histological sections stained with hematoxylin and
eosin were examined by a veterinary pathologist (LG). Peripheral
blood cytosmears and bone marrow cytospins (bone marrow cells
flushed with a 21-gauge needle in 2% FBS in PBS) were stained
with Wright’s stain and examined by a hematologist (GS).
Flow cytometry analysis of cells present in hematopoietic
organs
Bone marrow cells were isolated as mentioned above. Spleen
and thymus cells were gently dissociated through a nylon mesh in
2% FBS in PBS. Conjugated primary antibodies recognizing cell
surface epitopes used in these studies are: for erythroid and
megakaryocytic lineages: Ter119-APC (BioLegend, San Diego,
CA), CD71-PE (eBioscience, San Diego, CA), CD41-FITC (BD
Bioscience Pharmingen, Franklin Lakes, NJ); for myeloid lineages:
Cd11b-PE (BD Bioscience Pharmingen, Franklin Lakes, NJ), Gr1-
FITC (BD Bioscience Pharmingen, Franklin Lakes, NJ); for B cell
lineages: B220-APC (eBioscience, San Diego, CA), CD43-FITC
(BD Bioscience Pharmingen, Franklin Lakes, NJ); for T cells of the
bone marrow and spleen: CD4-FITC (BD Bioscience Pharmin-
gen, Franklin Lakes, NJ), CD8-APC (BD Bioscience Pharmingen,
Franklin Lakes, NJ); for hematopietic stem cell-enriched popula-
tions of the bone marrow: cKit-PE-Cy7 (eBioscience, San Diego,
CA), Sca1-PE (BD Bioscience Pharmingen, Franklin Lakes, NJ),
CD150-PE (Bioloegend, San Diego, CA), CD48-FITC (BD
Bioscience Pharmingen, Franklin Lakes, NJ), Ter119-APC, Gr1-
APC, and B220-APC; for T cells and other cells in the thymus:
cKit-PE-Cy7, CD25-APC, CD4-APC-Cy7, CD8-PerCP, TCRß-
FITC, CD19-APC, CD45.2-FITC, CD11c-PE-Cy7, Ly51-APC,
IAb-PE. The lineage negative population of the thymus was
stained with a cocktail of biotinylated antibodies (TCRab,
TCRcd, CD11b, CD11c, NK1-1, CD8, B220, Ter119, GR-1
and CD3) which were then labeled with APC-Cy7-Streptavidin.
All antibodies used in thymus experiments were from BD
Pharmingen, Franklin Lakes, NJ. Stained samples were processed
using an analytical flow cytometer (BD LSR II, BD Biosciences,
San Jose, CA, USA) and data analyzed with FlowJo software (Tree
Star Inc., Asland, OR, USA).
In vitro clonogenic progenitor assays
These assays were performed as previously described [19] with
cells isolated from the bone marrow and the spleen of two
Study of Murine Cystatin Genes
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heterozygous, and n=2 homozygous mutant mice). Cells were
seeded into semi-solid media (1 ml, in duplicate) at the following
densities: 4610
4 bone marrow cells/ml and 5610
5 spleen cells/ml
for myeloid clonogenic progenitor assays, and 2610
5 bone
marrow cells/ml and 2610
6 spleen cells/ml for B-lymphoid
clonogenic progenitor assay.
Competitive bone marrow reconstitution assay
E14.5 fetal liver cells were isolated from two independent wild-
type Pep3b mice (CD45.1
+) and two independent homozygous
mutant mice backcrossed with C57BL/6J mice for one generation
(CD45.2
+). In two independent settings, sublethally irradiated
Pep3b mice (800 cGy, n=4–5 mice) were transplanted with
1610
5 bone marrow helper cells (isolated from Pep3b mouse)
along with the following mixture of fetal liver cells: 0.5610
5 wild-
type + 2610
5 homozygous mutant. Peripheral blood was collected
from the tail vein at 12 weeks post-transplantation, erythrocytes
were lysed as described [20], and the percentage of CD45.1
+ and
CD45.2
+ circulating cells was determined by flow cytometry (see
above) using specific conjugated primary antibodies (CD45.1-APC
and CD45.2-FITC, BD Pharmingen , Franklin Lakes, NJ USA,
USA).
Susceptibility to irradiation-induced tumors
Mutant mice were backcrossed once in a C57BL/6J back-
ground and heterozygous mutant mice were intercrossed. Cohorts
of littermate animals (n=13 wild-type, n=30 heterozygous,
n=15 homozygous mutant mice) were sublethally irradiated
(whole body irradiation, 600 cGy of
137Cs c-irradiation) at 5 weeks
of age and monitored for tumor formation.
Cystatin phylogeny inference
Amino acid sequences of murine members of the cystatin
protein family (including Type 1, Stefins; Type 2, Cystatins; but
excluding Type 3, Kininogens) were collected using NCBI’s
Entrez Gene database [21]. The sequences were aligned with
ClustalW2 [22] using the Gonnet250 substitution matrix.
Adequate parameters for phylogeny inference were obtained by
submitting the produced alignment to the ProtTest evolutionary
model selection software [23]. Maximum Likelihood-based
phylogeny was then inferred using PhyML [24] using the
parameters suggested by ProtTest based on the Akaike Informa-
tion Criterion framework (AIC) score. Namely: the WAG
evolutionary model along with gamma correction and amino acid
frequency correction. Finally, robustness of the obtained tree was
evaluated by running 1000 bootstrap iterations.
Quantitative real-time PCR (qRT-PCR)
Mouse tissues were disrupted in Trizol using a Polytron
homogenizer and total cellular RNA was isolated according to
the manufacturer’s instructions (Invitrogen, Burlington, ON,
Canada). Two micrograms of RNA was reverse transcribed using
Superscript II Reverse Transcriptase (engineered version of M-
MLV Reverse Transcriptase) and random hexamers, according to
the manufacturer’s guidelines (Invitrogen Burlington, ON, Ca-
nada). Gene expression was assessed by qRT-PCR using the
Roche Light Cycler 480 with Roche Universal ProbeLibrary
assays, SYBR green assays (Stefin genes) or TaqMan assays
(endogenous control genes) as described in Table S3 and Text S1.
Reactions were performed in duplicate in 384 well plates for 50
amplification cycles (95uC1 0s ;6 0 uC1 0s ;7 2 uC 10 s). Primers for
SYBR green assays of stefin genes were carefully designed to
include nucleotides specific to the desired gene as determined by
multiple sequence alignment (Text S1). Specificity of SYBR green-
based assays was confirmed by melting curve analysis and
sequencing of amplicons. Reference gene assays (Gapdh and ß-
actin) were purchased from ABI (206 primer-probe mix, VIC
labeled). All other gene expression assays were designed using the
Roche Universal ProbeLibrary assay design software (Advanced
primer3 settings) and were tested for maximum efficiency by
standard curve analysis (slope=3.1–3.6). For a given cDNA
sample, threshold cycle (Ct) values were determined using the
Advanced Relative Quantification algorithm for each target gene
(Cttarget) as well as Gapdh and ß-actin endogenous reference genes
(Ctreference). cDNA control samples present on each plate insured
reliability of Ct values generated for each target and reference
gene studied, as expected from consistent PCR reactions.
Heatmaps were generated to represent the relative expression of
each target gene normalized to endogenous reference genes (e.g.
DCt=Cttarget2average Ctreference) for each given cDNA sample
(average from duplicate assays performed with cDNA derived
from 2 independent adult mouse tissues, from a pool of embryos,
or from 1–4 independent fetal livers, as indicated in the legends).
Heatmaps of the qRT-PCR data were produced using the R
‘heatmap’ function. Hierarchical clustering of the expression
profiles for both genes and samples was performed using the
complete linkage method and euclidian distance metric. To
compare relative gene expression in selected tissues of wild-type
mouse (calibrators for normalization) and of mutant mouse
(samples), reactions were performed in triplicate and the
comparative Ct method was employed (2
2DDCt; DDCt for a given
gene in a given tissue=DCtsample2DCtcalibrator). Relative gene
expression values for calibrators were set to 1.
Results
Generation of a homozygous mutant mouse line and
expression profiling of cystatin genes
We took advantage of a previously engineered mouse ESC line
containing a chromosomal deletion to assess the in vivo biological
functions of Csta and Stfa2l1 (stefins) as well as Fam162a, Ccdc58,
and associated intergenic regions (Figure 1A). The 95-kb
chromosomal deletion found in these ESCs specifically spans the
evolutionarily conserved coding sequences of Ccdc58, Csta, Stfa2l1
as well as the first coding exon of Fam162a (Figure 1A). These cells
were used to generate chimeric mice that transmitted the
chromosomal deletion successfully through the germline (not
reported before). Heterozygous animals appeared phenotypically
normal and could be intercrossed. At the time of weaning,
littermate animals of all expected genotypes were confirmed by
genotyping (Figure 1B) and were present at a Mendelian ratio
(32% wild-type, 44% heterozygous, and 24% homozygous;
n=100 monitored animals). PCR assays confirmed the loss of
genomic exons or adjacent regions throughout the area covered by
the chromosomal deletion in homozygous animals (Figure 1C). All
of these animals reached adulthood without phenotypic anomalies
(Figure 1D and characterization below).
In order to get an accurate perspective of the mouse stefin genes
within the cystatin superfamily, a list of cystatins and cystatin-like
candidates was extracted from NCBI’s Entrez Gene database [21]
(Table 1). Remarkably, genes encoding type 1 (e.g. stefins) and type
2 (e.g. cystatins) cystatins are grouped in two main clusters mapped
on mouse chromosome 16 and 2, respectively (Table 1), with the
exception of Cstb on chromosome 10 and Cst6 on chromosome 19.
Phylogeny inference based on amino acid sequences highlighted the
high degree of sequence similarity across stefin variants, which
Study of Murine Cystatin Genes
PLoS ONE | www.plosone.org 3 October 2009 | Volume 4 | Issue 10 | e7500Figure 1. Generation of mutant mice. (A) Representation of the 95-kb haploid chromosomal deletion found in an ESC clone (7–30) engineered by
a retroviral-based Cre-loxP system [1]. The schema was adapted from UCSC Genome Browser (http://genome.ucsc.edu/) [3]. Mammal conservation
(blue histogram) represents a evolutionary conservation measure across 20 placental mammal genomes. In addition, 8 pairwise alignments of
vertebrate genomes to the mouse genome can be found underneath (greyscale density plots) [3]. Also indicated, the recombined provirus
originating from the recombination of two independent proviruses (A1 and S1, see reference [1] for details). The coupling of the Pgk (murine
phosphoglycerate kinase promoter)-ATG in S1 to the neomycin (neo ATGless) gene in A1 allowed the selection of recombinant ESC clones. LTR, long
terminal repeat; SIN, long terminal repeat containing a deletion in the U3 region; c, LoxP site. (B) PCR-mediated genotyping (top panel) performed
with genomic DNA extracted from wild-type (+/+) ESCs, engineered ESCs (+/2), and mouse tail clips from littermate animals obtained by
intercrossing heterozygous (+/2) mice. Southern blot analysis performed with a neomycin probe (bottom panel, also see Figure 1A for EcoRI
enzymatic restriction digest pattern and neomycin probe localization) confirming the presence of the engineered allele in heterozygous or
homozygous (2/2) mutant animals. wt, wild-type allele; del, deleted allele. (C) PCR products spanning exons (ex) or intron-exon boundaries
confirmed the loss of the mapped genomic region in a representative homozygous animal (see Figure 1A for exon numbering and Table S2 for PCR
assay details). CTL, control. PCR for the Hprt1 gene was performed as a positive control in duplex or in parallel. (D) Representative photo of adult wild-
type and homozygous Del
16qB3D/16qB3D mice.
doi:10.1371/journal.pone.0007500.g001
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assays weredesignedtoestablishanintegratedtranscriptionalprofile
of Csta and Stfa2l1 within the cystatin gene network and to monitor
Fam162a and Ccdc58 expression in normal mouse tissues (Table S3).
Given the high degree of sequence similarity between some of the
stefinmembers(Figure2A),genesequencealignmentswererequired
to design SYBR green-based qRT-PCR assays specific to Stfa1
(detecting also BC117090 and BC100530), Stfa2, Stfa2l1,a n dStfa3
(Text S1 and Table S3). To confirm the specificity of these assays,
amplicons were sequenced to distinguish transcript unique nucleo-
tides (highlighted nucleotides in Text S1). TaqMan-like Roche
Universal ProbeLibrary assays were designed to monitor Csta, Cstb,
type 2 cystatin genes, Fam162a,a n dCcdc58 (Table S3). Global
expression analysis was performed with RNA extracted from
developing mouse embryos and E14.5 fetal liver cells (Figure S1)
as well as various tissues from male and female adult mice
(Figure 2B). Fam162a, Ccdc58,a n dCst3 were highly expressed in
all analyzed tissues (Figures S1 and 2B). Expression of several
cystatin genes (type 1 and 2) was detected during embryogenesis
(Figure S1). Theywere alsoexpressed invarious combinations in the
tissues of adult animals, ranging from few to several expressed
membersdepending on the tissue analyzed (forexample, see cystatin
gene expression in liver versus testis, Figure 2B). Within the stefin
subgroup, Csta, Cstb,a n dStfa3 were expressed in a variety of tissues
whileStfa1,Stfa2,an dStfa2l1presentedrestrictedexpressionpatterns
(Figures 2B and S1). Several stefin members were expressed in the
hematopoietic organs (e.g. bone marrow, spleen, thymus, and fetal
liver) (Figures S1 and 2B). Stfa2l1 expression was weak or
undetectable in most tissues tested, with the notable exception of
the fetal liver, bone marrow, and spleen which presented high
expression levels (Figures S1 and 2B). Stfa2l1 and Csta (stefins) gene
expression patterns in adult mouse tissues were similar to the one
observed for Stfa3 (stefin) (Figure 2B). According to the clustering of
the qRT-PCR results, Stfa1 & Stfa2 (stefins) gene expression profiles
shared similarity with the ones observed for Cst6 & Cst10 (type 2
cystatins) in adult mouse tissues (Figure 2B). In selected embryonic
tissues, Stfa2l1, Stfa2,a n dStfa3 expression profiles clustered together
while Csta expression pattern shared similarity with other cystatin
genes (Figure S1). Although Stfa1 (as well as BC117090 and
BC100530) mapped to the same chromosomal cluster as Stfa2l1,
Stfa2 and Stfa3 (Table 1) and presented high similarity at the amino
acids sequence level (Figure 2A), its expression was distinctively
restricted to E14.5 fetal liver cells among the tissues analyzed
(Figures S1 and 2B). Together these results demonstrate that even
though stefin and cystatin genes map predominantly to distinct
chromosomal clusters and encode two divergent sets of proteins,
they present an assortment of expression profiles sharing both intra-
and inter-group similarity in mouse tissues. Among the genes
covered by the deletion (Del
16qB3D/+), Fam162a and Ccdc58 are
expressed ubiquitously in mouse tissues, Csta expression is detected
in several tissues (low levels), and Stfa2l1 is mainly expressed in
hematopoietic organs.
Mutant mice are phenotypically normal, fertile, and not
susceptible to tumor formation
No differences could be observed between adult homozygous
mutant mice and control littermate animals in terms of general
appearance (including inspection of eyes, ears, fur, claws, and
teeth), body weight (18.663.4 g for wild-type; 19.763.1 g for
homozygous mutant; n=3 animals monitored) and length
(8.660.5 cm for wild-type; 8.160.5 cm for homozygous mutant;
n=3 animals monitored), response to stimuli (visual, aural, pain)
and neuromuscular function (grip strength test). Clinical serum
biochemistry and urinalysis of representative homozygous mutant
and control littermate animals did not reveal significant differences
for a panel of standard clinical assays (Table 2). Comparative
histological analysis of fetuses (E12.5, E14.5, and E16.5) and
various tissues (bone marrow, spleen, thymus, heart, kidney,
muscle, brain, salivary gland, lung, stomach, pancreas, liver,
intestine, colon, testis, bulbourethral gland, seminal vesicle, uterus,
ovary, and mammary gland) from adult homozygous mutant mice
and control littermates did not reveal any phenotypic differences
(LG, data not shown). Both male and female homozygous mutant
mice were fertile, producing litters of normal size that were
composed of male and female animals (data not shown). To date,
homozygous mutant and control littermate animals were moni-
tored for one year without developing symptomatic diseases or
tumors. In order to induce tumor formation, a cohort of wild-type
(n=13), heterozygous mutant (n=30), and homozygous mutant
(n=15) littermate animals were submitted to whole body c-
irradiation (600 cGy) at 5 weeks of age and monitored for
symptomatic tumor formation over a period of 5 months.
According to the observation time, all of the mice appeared to
be healthy except for a heterozygous and a homozygous mutant
mouse that died 154 days post-irradiation (unknown causes, data
Table 1. List of type 1 & 2 cystatin genes, chromosomal
localization, and corresponding protein names.
Cystatin
Category
Cystatin gene
name Chr Protein name
Type 1
(Stefins)
Cstb 10qC1 Cystatin B
Csta* 16qB3 Cystatin A
Stfa2l1* 16qB3 Stefin A2-like 1
Gm5483 16qB3 EG433016 protein
Gm5416 16qB3 Stefin A1-like 1
2010005H15Rik 16qB3 Hypothetical protein LOC76770
Stfa1 16qB3 Stefin A1
BC117090 16qB3 Stefin A1-like protein
BC100530 16qB3 Stefin A-like protein
Stfa2 16qB3 Stefin A2
Stfa3 16qB3 Stefin A3
Type 2
(Cystatins)
Cstl1 2qG3 Cystatin-like 1 isoform 3
Cst11 2qG3 Cystatin 11
8030411F24Rik 2qG3 Cystatin SC
Cst13 2qG3 Cystatin 13
9230104L09Rik 2qG3 Cystatin E2
Cst12 2qG3 Cystatin-related epididymal
spermatogenic protein 3 (RESP3)
Cst8 2qG3 Cystatin 8 (cystatin-related
epididymal spermatogenic)
Cst9 2qG3 Cystatin 9
Cst3 2qG3 Cystatin C
Gm14129 2qG3 Cystatin AP4
Gm1330 2qG3 Cystatin AP5
Cst10 2qG3 Cystatin 10 (chondrocytes)
Cst7 2qG3 Cystatin F (leukocystatin)
Cst6 19qA Cystatin E/M
*Gene deleted in Del
16qB3D/+ ESCs. Chr, chromosomal localization.
doi:10.1371/journal.pone.0007500.t001
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PLoS ONE | www.plosone.org 5 October 2009 | Volume 4 | Issue 10 | e7500Figure 2. Comprehensive analysis of type 1 and 2 mouse Cystatins. (A) Phylogeny inference of type 1 and 2 cystatins based on amino acids
sequence comparison. Numbers represent the degree of confidence of the nodes, as evaluated by the bootstrap test (highest degree of confidence:
1000). *Genes deleted in Del
16qB3D/+ ESCs. (B) DCt heatmap representing the expression profiles of Fam162a, Ccdc58, and several cystatin genes in the
indicated tissues of adult mice (n=2 independent tissues analyzed in duplicate, see Material and Methods section for details). Note that the qRT-PCR
assay for Stfa1 also detects BC117090 and BC100530 transcripts. DCt above 15 represents weak gene expression or no expression; the expression cut-
off varies according to each specific qRT-PCR assay (between DCt 15–25).
doi:10.1371/journal.pone.0007500.g002
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normal in a specific-pathogen-free (SPF) animal facility.
Functional characterization of hematopoietic lineages
Since the four genes encompassed by the chromosomal deletion
appeared to be transcriptionaly active in organs highly enriched
with hematopoietic cells such as the fetal liver, the bone marrow,
the spleen, and the thymus (Figures 1B and S1), a functional
characterization of the hematological system was performed. First,
similar clinical hematologic profiles were obtained using blood
isolated from representative wild-type, heterozygous, and homo-
zygous mutant littermate animals (Table 3). Then, adult mice were
sacrificed to isolate bone marrow, spleen and thymus cells. The
cellularity of these organs was similar for all littermate animals
(data not shown). A series of antibodies specific to cell surface
antigens allowed us to monitor the proportion of various
hematopoietic lineages as well as stromal cells by flow cytometry
(Table 4 and data not shown). Normal distributions of committed
progenitors and differentiated cell lineages were observed in the
bone marrow, spleen and thymus of mutant mice and control
littermate animals (Table 4). Also, flow cytometry analysis revealed
that the bone marrow cell compartments enriched in long-term
repopulating hematopoietic stem cells, defined here as KLS (c-Kit
+
Sca1
+ lineages
2) or C150
+CD48
2 lineages
2 populations [25],
were similar in mutant and wild-type littermate animals (Table 4).
Because cathepsins regulate major histocompatibility complex II
(MHC II) antigen processing and stefins are cathepsin inhibitors
[26], MHC II expression was monitored on Del
16qB3D/16qB3D
dendritic cells (CD45
+ CD11c
+) using IAb immunostaining and
flow cytometry. Normal cell surface expression of MHC class II
molecules was observed on dendritic cells isolated from the thymus
of mutant and control littermate animals (data not shown). In
addition, myeloid and B-lymphoid clonogenic progenitor assays
performed with cells isolated from the bone marrow and spleen of
Table 2. Clinical serum biochemistry and urinalysis of mutant mice and control littermates
a.
Assays Units Range M (+/+)M ( +/2) M( 2/2) F( +/+) F( +/2) F( 2/2)
Serum biochemistry
Total Protein g/L 36–66 46 71 47 59 59 43
Albumin g/L 25–48 24 39 21 24 35 22
Albumin/Globulin ratio 1.1 1.2 0.8 0.7 1.5 1.0
Glucose mmol/L 5.0–10.7 10.6 10.2 9.7 12.1 8.2 8.9
Blood urea nitrogen mmol/L 6.4–10.4 10.9 9.0 10.3 7.2 8.6 8.2
Creatinine mm o l / L 1 8 – 7 1 2 2n . d . 2 81 32 41 6
Total Bilirubin mmol/L 2–15 11 40 8 37 22 6
Alanine transaminase U/L 28–132 26 197 26 39 121 67
Aspartate transaminase U/L 59–247 929 3929 722 1080 2766 936
Alkaline phosphatase U/L 62–209 73 97 82 56 91 93
Gamma-glutamyl transferase U/L 7 n.d. 6 15 12 6
Cholesterol mmol/L 0.93–2.48 2.22 n.d. 3.32 2.67 3.24 2.54
Sodium mmol/L 124–174 151 n.d. 150 146 .250 151
Potassium mmol/L 4.6–8.0 6.7 n.d. 6.9 13.2 .14.0 6.4
Chloride mmol/L 92–120 110 n.d. 110 107 114 120
Calcium mmol/L 1.47–2.35 2.20 2.15 2.30 2.40 2.60 2.08
Phosphorus mmol/L 1.97–3.26 1.79 2.37 1.83 2.02 3.18 2.59
Magnesium mmol/L 0.33–1.60 1.04 0.33 1.04 1.11 1.44 0.97
Urinalysis
Color yellow yellow yellow yellow yellow Yellow
Clarity clear clear clear hazy clear Clear
Specific Gravity 1.015 1.015 1.020 1.020 n.d. n.d.
pH n.d. n.d. 6 6 n.d. n.d.
Leukocytes n.d. n.d. negative n.d. n.d. n.d.
Nitrites n.d. n.d. negative n.d. n.d. n.d.
Proteins 1+ 1+ 1+ 1+ negative Negative
Glucose normal normal normal normal normal Normal
Ketones negative negative negative negative n.d. n.d.
Urobilinogen n.d. n.d. normal n.d. n.d. n.d.
Bilirubin n.d. n.d. negative negative n.d. n.d.
Blood/Hemoglobin 1+ negative negative 1+ n.d. n.d.
aClinical serum biochemistry and urinalysis were performed with different sets of representative animals. M, male; F, female; +/+, wild-type; +/2, heterozygous Del
16qB3D/+;
2/2, homozygous Del
16qB3D/16qB3D ; n.d., not determined.
doi:10.1371/journal.pone.0007500.t002
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quantitative anomalies (Figure 3A–C). Finally, the long-term
reconstitution capacity of hematopoietic stem cells isolated from
E14.5 fetal livers was evaluated functionally by a competitive
reconstitution assay. Homozygous mutant fetal liver cells (express-
ing the common leukocyte antigen CD45.2) from two mice were
independently mixed at 80% ratio with wild-type fetal liver cells
(CD45.1
+) and reintroduced into 3 to 5 sublethally irradiated hosts
(CD45.1
+) together with a defined number of wild-type bone
marrow helper cells (CD45.1
+) to assist in short-term reconstitu-
tion. The hematopoietic chimerism (proportion of circulating
CD45.1
+ or CD45.2
+ cells) in the peripheral blood was assessed by
flow cytometry twelve weeks following bone marrow transplanta-
tion. When transplanted in a competitive setup (i.e., 80% mutant
CD45.2
++20% control competitor CD45.1
+ cells), homozygous
mutant fetal liver cells contributed at high level to the
hematopoietic system of the hosts (69.4664.34% CD45.2
+, see
Figure 3D for a representative flow cytometry profile). These
observations revealed that homozygous mutant hematopoietic
stem cells with long-term repopulating capacity could efficiently
home and function in the hematopoietic organs of the transplanted
hosts. Together, these results suggest that the hematopoietic
system of the homozygous Del
16qB3D/16qB3D mutant mice is normal.
Transcriptional profiling of mutant hematopoietic tissues
Surprisingly, the loss of four contiguous genes in the mouse
genome did not compromise embryonic development or homeo-
stasis in adult animals. As expected, qRT-PCR analysis revealed
that Ccdc58, Csta, Stfa2l1 mRNA expression levels were signifi-
cantly reduced in selected tissues (fetal liver, bone marrow, spleen,
and thymus) of the homozygous Del
16qB3D/16qB3D animals in
comparison to control wild-type animals, confirming that these
genes are completely deleted from the genome of these mice
(Figure 4 A–D). Notably, deleting the first coding exon of Fam162a
drastically decreased its transcript levels in selected tissues of
homozygous Del
16qB3D/16qB3D animals compared to wild-type
littermates (qRT-PCR primers hybridize to exons 3 and 4,
Figures 1A and 4A–D). The potential subsistence of truncated
Fam162a proteins was not evaluated.
One hypothesis to explain the apparent lack of phenotypic
anomalies in the homozygous Del
16qB3D/16qB3D mice could be that
related genes are compensating for the deleted components.
Table 3. Clinical hematological studies of wild-type and mutant littermate animals.
Assays Units M (+/+)M ( +/2)M ( 2/2)F ( +/+)F ( 2/2)
Hematocrit L/L 0.464 0.471 0.489 0.461 0.482
Hemoglobin g/L 161 163 168 163 166
Red blood cells 610
12/L 10.27 10.24 11.07 10.20 10.87
Mean cell volume fL 45 46 44 45 44
Mean cell hemoglobin pg 15.6 16.0 15.2 16.0 15.2
Mean cell hemoglobin concentration g/L 346 347 344 353 344
White blood cells 610
9/L 7.2 10.7 6.1 6.9 9.8
Neutrophils % 56 62 53 18 39
Lymphocytes % 41 36 46 78 59
Monocytes % 1 0 1 0 0
Eosinophils % 2 2 0 4 2
Band % 0 0 0 0 0
Metamyelocyte % 0 0 0 0 0
Myelocyte % 0 0 0 0 0
Promyelocyte % 0 0 0 0 0
Other % 0 0 0 0 0
Blast % 0 0 0 0 0
Neutrophils 610
9/L 4.03 6.63 3.23 1.24 3.82
Lymphocytes 610
9/L 2.95 3.85 2.81 5.38 5.78
Monocytes 610
9/L 0.07 0.00 0.06 0.00 0.00
Eosinophils 610
9/L 0.14 0.21 0.00 0.28 0.20
Band 610
9/L 0.00 0.00 0.00 0.00 0.00
Metamyelocyte 610
9/L 0.00 0.00 0.00 0.00 0.00
Myelocyte 610
9/L 0.00 0.00 0.00 0.00 0.00
Promyelocyte 610
9/L 0.00 0.00 0.00 0.00 0.00
Other % 0.00 0.00 0.00 0.00 0.00
Blast 0.00 0.00 0.00 0.00 0.00
Platelets 610
9/L 549 722 882 628 769
Poikilocyte occ occ occ occ 2+
M, male; F, female; +/+, wild-type; +/2, heterozygous Del
16qB3D/+; 2/2, homozygous Del
16qB3D/16qB3D ; occ, occasional.
doi:10.1371/journal.pone.0007500.t003
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described above, the stefins appeared as candidates for sharing
functions with Stefin A2-like 1 and Cystatin A (Figures 2A–B and S1).
The hematopoietic tissues (fetal liver, bone marrow, spleen, and
thymus) were selected to evaluate by qRT-PCR whether potential
compensation for the loss of Stfa2l1 and Csta in mutant animals could
occur through increased mRNA levels of Stfa2 and Stfa3 (expressed at
significant levels in these organs) as well as Stfa1 (highly expressed in
wild-type fetal liver cells)( F i g u r e s2 B ,S 1 ,a n d4 A – D ) .Cst3 (type 2
cystatin), which maps to a chromosomal cluster distinct from the stefin
genes and was ubiquitously expressed in adult and embryonic tissues,
was additionally selected as a control (Table 1, Figures 2A–B, S1, and
4A–D). Interestingly, distinctive upregulation of gene expression could
be observed for Stfa1, Stfa2,a n dStfa3 in the hematopoietic tissues of
adult heterozygous Del
16qB3D/+ and homozygous Del
16qB3D/16qB3D mice
compared to wild-type animals, but this phenomenon was not
observed in the fetal liver cells (Figure 4A–D). In contrast, Cst3 levels
remained relatively constant (Figure 4A–D). Taken together, these
results confirmed the lack of expression of the deleted genes (Fam162a,
Ccdc58, Csta,a n dStfa2l1) and the increased transcriptional levels
of selected stefin genes in the hematopoietic tissues of adult
Del
16qB3D/16qB3D animals, suggestive of compensatory mechanisms,
and thus possibly explaining the lack of observed phenotypic defect.
Discussion
A comprehensive analysis of type 1 and 2 mouse cystatin genes was
undertaken, revealing that these phylogenetically distinct sub-
Table 4. Proportion of hematopoietic progenitors and differentiated cells in bone marrow, spleen, and thymus analysed by flow
cytometry
a.
Wild-type Heterozygous Homozygous
(%) (%) (%)
Bone marrow
Megakaryocytic-erythroid progenitors (CD41
+ Ter119
+) 0.6360.19 0.6060.30 0.5260.11
Megakaryocytes (CD41
+ Ter119
2) 5.3960.96 4.0760.76 4.1360.83
Erythroblasts (CD71
+ Ter119
+) 23.8363.80 27.8860.29 25.3865.09
Erythrocytes (CD71
2 Ter119
+) 1.3161.34 0.2760.24 0.6060.49
Granulocyte-macrophage progenitors ( Gr1
+ CD11b
+) 18.4262.28 18.1162.05 20.3062.38
Granulocytes (Gr1
+ CD11b
2) 1.4460.12 1.2660.47 1.4260.17
Macrophages (Gr1
2 CD11b
+) 1.4560.25 1.2660.13 1.2160.04
Pre-B cells (CD43
+ B220
+) 0.8060.31 0.6060.19 1.2560.13
Mature B cells (CD43
2 B220
+) 34.1063.33 26.7864.55 26.1968.86
T cells (CD4
+ CD8
+) 0.1160.03 0.2060.10 0.1560.01
T cells (CD4
+ CD8
2) 1.0960.15 1.3760.51 0.7660.09
T cells (CD4
2 CD8
+) 0.3660.30 0.2760.23 0.1260.04
HSC- enriched KLS (c-Kit
+ Sca1
+ Lin
2b) 0.12960.103 0.07960.013 0.07760.028
HSC-enriched CD150
+ CD48
2 Lin
2b 0.02560.008 0.09160.075 0.03060.016
Spleen
Granulocyte-macrophage progenitors and macrophages (CD11b
+) 1.1660.22 1.8960.01 1.6160.56
Pre-B cells (CD43
+ B220
+) 0.5760.37 0.6160.25 0.8960.69
Mature B cells (CD43
2 B220
+) 64.2162.45 60.1462.53 49.1768.74
T cells (CD4
+ CD8
+) 0.0660.03 0.1560.01 0.1260.09
T cells (CD4
+ CD8
2) 16.7961.07 15.6961.95 20.1363.93
T cells (CD4
2 CD8
+) 0.6460.69 1.7161.44 0.7860.87
Thymus
T cells (CD4
+ CD8
+) 84.1060.42 73.9568.98 79.4065.94
T cells (CD4
+ CD8
2) 10.6560.07 16.2061.41 13.9063.96
T cells (CD4
2 CD8
+) 1.4060.00 2.2060.42 1.4060.85
Dentritic cells (CD45
+ CD11c
+) 0.1560.07 0.2060.00 0.2060.00
Stromal cells (CD45
2) 0.7260.10 0.5560.16 1.0060.85
ETP (Lin
2c c-Kit
Hi CD25
Lo) 0.01460.007 0.01760.008 0.01960.012
DN2 T cells (Lin
2c c-Kit
Hi CD25
Hi) 0.02860.015 0.03560.031 0.04360.017
DN3 T cells (Lin
2c c-Kit
Lo CD25
Hi) 1.3560.20 0.9460.56 1.3260.01
aCellular populations were gated to exclude debris, dead cells and enucleated erythrocytes. Two mice of each genotype were analyzed (one male and one female).
bDepletion of erythroid (Ter119), granulocytes (Gr1), and B cell (B220) lineages.
cDepletion of TCRab
+,T C R cd
+, NK1-1
+, CD8
+, CD3
+, B220
+, CD11b
+, CD11c
+,G r 1
+ and Ter119
+ cells. ETP, early T-cell precursor; DN2 & DN3, double negative phase 2&3;
Hi, high expression level; Lo, low expression level.
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PLoS ONE | www.plosone.org 9 October 2009 | Volume 4 | Issue 10 | e7500Figure 3. Hematopoietic system characterization. (A–C) Clonogenic hematopoietic progenitor assays. Distribution of the number of
hematopoietic colonies derived from myeloid clonogenic progenitors isolated from the bone marrow (A, seeding density of 4610
4 cells) or the
spleen (B, seeding density of 5610
5 cells) of n=2 animals of each indicated genotype. GM, granulocyte-macrophage progenitor; GEMM, granulocyte-
erythrocyte-macrophage-megakaryocyte progenitor; M, macrophage progenitor; G, granulocyte progenitor; BFU-E, erythroid blast-forming unit. (C)
Number of hematopoietic colonies derived from B-lymphoid clonogenic progenitors isolated from the bone marrow (seeding density of 2610
5 cells)
or spleen (seeding density of 2610
6 cells) of n=2 animals of each indicated genotype. (D) Competitive hematopoietic reconstitution assay.
Representative flow cytometry profiles of peripheral blood cells stained with antibodies specific to allelic forms of the cell surface marker
CD45: CD45.1
+ Pep3b recipient mouse (top left profile), CD45.2
+ C57BL/6J control mouse (top right profile), and immunophenotyping performed 12
weeks following the transplantation (tx) of the indicated ratio of Del
16qB3D/16qB3D (CD45.2
+) and wild-type (CD45.1
+) fetal liver cells (bottom profile).
Del
16qB3D/16qB3D fetal liver cells efficiently contributed to the hematopoietic reconstitution of the host (D, bottom profile, bottom right quadrant). Note
that the small proportion of double positive CD45.1
+ CD45.2
+ cells (D, bottom profile, upper right quadrant) represents a technical artefact;
hematopoietic cells in reconstituted animals are exclusively positive for one of the two CD45 allelic forms.
doi:10.1371/journal.pone.0007500.g003
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inter-group expression profile similarities. The optimization of specific
qRT-PCR assays was critical to establish the cystatin transcriptional
signature in normal mouse tissues. These assays will be suitable to
assist in the characterization of cancer and other diseases modeled in
mice that are associated with altered expression of cystatin genes.
Figure 4. Comparative expression profiling of wild-type and mutant hematopoietic tissues. (A–D) Relative gene expression monitored by
qRT-PCR using RNA extracted from hematopoietic tissues of 2–4 independent mice for each indicated genotype (+/+, wild-type; +/2, heterozygous
Del
16qB3D/+; and2/2, homozygousDel
16qB3D/16qB3D). Average expressionlevel ofeach indicatedgene in each wild-typetissuewasused as a calibrator for
normalization (see MaterialandMethodsfordetails).Relativegeneexpression observedforeach independent tissue is representedbya coloreddotor a
D when the result is below the detection level of the assay; relative gene expression average is represented by an horizontal bar. Loss of expression of
Fam162a, Ccdc58, Csta, andStfa2l1wasconfirmed in Del
16qB3D/16qB3D mouse tissues.Distinctiveincreasesin transcriptional levels were observedforStfa1,
Stfa2,andStfa3intissuesofheterozygousDel
16qB3D/+andhomozygousDel
16qB3D/16qB3Dadultmicecomparedtowild-type(B–D),butnotinthefetallivers
(A). Note that Stfa1 qRT-PCR primers also detect BC117090 and BC100530 gene expression. *, Genes deleted in Del
16qB3D/+ ESCs.
doi:10.1371/journal.pone.0007500.g004
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(Del
16qB3D/16qB3D) was generated following the successful germline
transmission of a chromosomal deletion previously engineered in
ESCs using a retroviral-based system of Cre-loxP recombination
(Figure 1A–D). This illustrates how the collection of mutant ESC
clones published [1], now part of a larger library named DelES
(e.g. Deletion in Embryonic Stem Cells, manuscript in prepara-
tion), is suitable to perform in vivo phenotypic studies of dominant
and recessive mutations in embryonic, extraembryonic, and adult
tissues. As indicated by the assays employed here, mice deficient in
Fam162a, Ccdc58, Csta, and Stfa2l1 appeared normal, healthy, and
fertile when maintained in an SPF animal facility (Table 2–4,
Figures 1 and 3). These observations were unexpected given that
the four deleted genes span a vast spatio-temporal spectrum of
gene expression (Figures 2B and S1). Other proteins could possibly
functionally compensate for these losses. Increased expression of
selected stefin genes (Stfa1, Stfa2, and Stfa3) was observed in the
hematopoietic organs of adult mutant mice suggesting that they
might be participating in compensation mechanisms (Figure 4B–
D). Mutant fetal liver cells presented stable Stfa1, Stfa2, and Stfa3
transcriptional levels potentially because of the endogenous high
expression of the selected genes, functional compensation by other
cystatin members, or dispensability of Csta and Stfa2l1 for their
functions (Figures 4A and S1). Compensation mechanisms are
likely to be complex and variable according to each particular
tissue and discrete developmental stage, without necessarily
requiring changes at the transcriptional level. Additional genetic
studies, such as the chromosomal deletion of the complete stefin
gene cluster mapped on mouse chromosome 16 or the cystatin
gene cluster mapped on chromosome 2, would be required to
potentially uncover and dissect compensation mechanisms that
might be occurring in the mutant mouse model presented here.
Phylogenetic and expression studies of Fam162a and Ccdc58 related
family members will also be necessary.
Decreased expression level of Csta has been observed in
particular types of human cancer such as gastric carcinoma [11],
esophageal squamous cell carcinoma [10], and head and neck
squamous cell carcinoma [13]. However, increased expression of
Csta has also been observed in lung tumors and carcinomas of the
oropharynx [12,14]. Moreover, overexpression of Csta appears to
decrease metastasis potential of mammary tumors and esophageal
squamous cell carcinoma in animal models [15,16]. In this
context, it is remarkable that homozygous mutant mice monitored
for one year did not spontaneously develop symptomatic tumors.
Given that most cancers are generated through multi-step
processes, it would be of interest to analyze the effect of the
chromosomal deletion in a sensitized genetic background prone to
the development of the specific types of tumors mentioned above.
In this study, the effect of the chromosomal deletion was
monitored in mice sensitized for tumor development by c-
irradiation. Mice have been monitored for 5 months and did not
develop symptomatic tumors. Among the factors affecting the
latency and the spectrum of tumors induced by c2irradiation are
the irradiation dose and the genetic background of the mice
(genetic background of mouse strain as well as presence of defined
genetic mutations). The c2irradiation dose used in this study
(600 cGy) has been shown to be sufficient to accelerate the
development of lymphomas in Eed hypomorphic mutant mice
prior to 200 days post-irradiation, while wild-type control mice
remained healthy (note that Eed mutant mice were backcrossed for
more than 10 generations in a C57BL/6J background) [27]. It will
be of interest, following a longer latency, to analyze various
irradiated mouse tissues histologically, in order to look for
asymptomatic tumors as described for wild-type and p21-tumor
suppressor mutant mice exposed to a whole body c2irradiation
[28].
In addition, it would be interesting to challenge the immuno-
logical response of the homozygous mutant mice since stefin
proteins are reported to modulate antigen presentation by
regulating cathepsins [7]. Also, the effect of the chromosomal
deletion could be studied in a sensitized background of
autoimmune disease which is thought to involve stefin proteins
[8,9].
Overall, this study reveals that the homozygous chromosomal
deletion of Fam162a, Ccdc58, Csta, Stfa2l1 and associated intergenic
regions is permissive for the development and homeostasis of adult
mice. A phylogenetic study and qRT-PCR assays were developed
to globally monitor expression of type 1 and 2 cystatin genes in
normal mouse tissues and to gain insight into potential
compensation mechanisms involved in Csta/Stfa2l1 mutant tissues.
These new tools will be of great value to characterize mouse
models of human diseases associated with aberrant cystatin gene
expression.
Supporting Information
Table S1 PCRassaysusedforgenotyping mutantembryonicstem
cells or mice (engineered deletion present on chromosome 16).
aA
duplex reaction was set up with three primers (double concentration
of the common reverse primer).
bPCR reactions were conducted
separately.
Found at: doi:10.1371/journal.pone.0007500.s001 (0.02 MB
XLS)
Table S2 PCR assays to monitor the loss of the genomic
segment
a.
aPCR primers were designed either to flank both sides of
a genomic exon or one primer was flanking a given exon and a
second one was hybridizing inside the exon for specificity reasons.
Chr, chromosome.
Found at: doi:10.1371/journal.pone.0007500.s002 (0.02 MB
XLS)
Table S3 Quantitative real-time PCR assays.
aPrimers common
to transcripts: Stfa1, BC117090 and BC100530. Nucleotides
identified in blue are specific to the target genes (see gene
sequence alignments in Text S1). *Gene deleted in Del
16qB3 D/+
ESCs.
Found at: doi:10.1371/journal.pone.0007500.s003 (0.02 MB
XLS)
Text S1 Sequence alignments of Stefin-genes cluster (chromo-
some 16) were used to design qRT-PCR primers specific to Stfa1,
Stfa2, Stfa2l1, and Stfa3 (underlined in red, see primers sequences
in Table S3).
Found at: doi:10.1371/journal.pone.0007500.s004 (0.24 MB
RTF)
Figure S1 Gene expression during mouse embryogenesis. DCt
heatmap representing the expression profiles of Ccdc58, Fam162a,
and several cystatin genes in the indicated tissues. Sample sizes are
the following: n=1 pool of embryos (E11.5, E10.5, and E9.5);
n=4 independent E14.5 fetal livers for Fam162a, Ccdc58, Csta,
Stfa2l1, Stfa1, Stfa2, Stfa3, and Cst3 assays; and n=1 E14.5 fetal
liver for other qRT-PCR assays. Assays were conducted in
duplicate, see Material and Methods section for details. qRT-PCR
assay for Stfa1 also detects BC117090 and BC100530 transcripts.
DCt above 15 represents weak gene expression or no expression;
the expression cutoff varies according to each specific qRT-PCR
assay (between DCt 15–25). *, Genes deleted in Del
16qB3 D/+ ESCs.
E, embryonic day.
Found at: doi:10.1371/journal.pone.0007500.s005 (0.33 MB TIF)
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